-
The microbiological laboratory of LLC “BioJet” successfully passed the inspection by Rospotrebnadzor experts
Read more: The microbiological laboratory of LLC “BioJet” successfully passed the inspection by Rospotrebnadzor expertsAs a result of the inspection, the laboratory received a positive Sanitary and Epidemiological Conclusion and a license from Rospotrebnadzor for working with microorganisms of III-IV pathogenicity groups.
-
Takeda Finds Buyer for Its Yaroslavl Manufacturing Facility
Read more: Takeda Finds Buyer for Its Yaroslavl Manufacturing FacilityJapanese pharmaceutical company Takeda has received approval from the Russian Government Commission for Control over Foreign Investments to sign an agreement with Binergiya JSC. Under the deal, Takeda plans to transfer rights to commercialize part of its retail drug portfolio — which is considered non-core for the company — as well as its production site…
-
What Pharmaceutical Sovereignty Will Look Like in Russia
Read more: What Pharmaceutical Sovereignty Will Look Like in RussiaThe development of a full-cycle pharmaceutical industry in Russia is seen as the key to long-term drug security and the country’s technological sovereignty. Achieving this requires coordinated efforts among regulators, businesses, and the scientific community. GxP News explored which development priorities each side considers most important. The geopolitical challenges of recent years have pushed the…
-
Crystalline DNA “Flowers” Created for Targeted Drug Delivery
Read more: Crystalline DNA “Flowers” Created for Targeted Drug DeliveryThey can unfold and fold up to ten times, enabling multiple uses. American chemists have developed nanocrystals made from DNA strands and inorganic molecules that can repeatedly open and close in response to changes in environmental conditions — much like flowers do. This property allows the DNA “flowers” to be used for packaging and targeted…
-
Healthy Lifestyle vs. “Magic Pills”: How Russia Is Working to Extend Life Expectancy
Read more: Healthy Lifestyle vs. “Magic Pills”: How Russia Is Working to Extend Life ExpectancyRussia’s Minister of Health, Mikhail Murashko, has called for a reconsideration of traditional views on aging. According to him, the key priorities for modern healthcare are extending healthy life expectancy and slowing the progression of diseases — including through the use of digital technologies. Earlier, social media was abuzz with claims that some people could…
-
Russian Health Ministry Estimates Share of Domestic Medicines at 70% by Number of Packages
Read more: Russian Health Ministry Estimates Share of Domestic Medicines at 70% by Number of PackagesThe ratio of Russian to foreign medicines in the pharmaceutical market by the number of packages is 70 to 30, said Health Minister Mikhail Murashko while addressing the State Duma. “Today, the ratio of domestic to foreign pharmaceutical products in the market stands at 70 to 30 by number of packages. In monetary terms, the…
-
WHO names the main causes of mortality among Russians
Read more: WHO names the main causes of mortality among RussiansThe majority of deaths in Russia are caused by cardiovascular diseases and related conditions. More than 80% of deaths in the country are linked to cardiovascular diseases, malignant neoplasms, chronic respiratory illnesses, and diabetes, said Batyr Berdyklychev, head of the World Health Organization (WHO) office in Moscow, in an interview with RIA Novosti. “The main…
-
Ocrelizumab production may be localized in Russia in 2026
Read more: Ocrelizumab production may be localized in Russia in 2026In August 2025, the Federal Center for Planning and Organization of Drug Provision (FCPiLO) of the Russian Ministry of Health announced the largest procurement in three years for the drug with the active substance ocrelizumab, worth 17.7 billion rubles. However, the tender was canceled and reissued in early September with revised parameters: the requested volumes…
-
The most expensive medicines in Russia have been named
Read more: The most expensive medicines in Russia have been namedIT company Cursor has compiled a list of the most expensive medicines registered in Russia. The top ten includes four products from Swiss company Novartis (occupying the top three positions), as well as two from UK-based AstraZeneca. GxP presents a brief version of the ranking. In August, U.S. pharmaceutical publication Fierce Pharma presented its ranking…
-
Ministry of Industry and Trade increases the cost of pharmaceutical manufacturing inspections
Read more: Ministry of Industry and Trade increases the cost of pharmaceutical manufacturing inspectionsThe Ministry of Industry and Trade of the Russian Federation (Minpromtorg) has raised the cost of pharmaceutical inspections of drug manufacturing both in Russia and abroad, as well as inspections for compliance with the rules of the Eurasian Economic Union (EAEU). The same order also allows the ministry to revise service fees annually by September…